Myrbetriq and Activella drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Myrbetriq (mirabegron) and Activella (estradiol; norethindrone acetate). Common drug interactions include dyspnoea among females.
The phase IV clinical study analyzes what interactions people have when they take Myrbetriq and Activella. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.
What is Myrbetriq?
Myrbetriq has active ingredients of mirabegron. It is often used in urge incontinence. eHealthMe is studying from 33,658 Myrbetriq users. Check the latest studies of Myrbetriq.
What is Activella?
Activella has active ingredients of estradiol; norethindrone acetate. It is often used in menopause. eHealthMe is studying from 1,971 Activella users. Check the latest studies of Activella.
11 people who take Myrbetriq and Activella together, and have interactions are studied.
What are the common drug interactions of Myrbetriq and Activella, by gender? *:
female:
- Dyspnoea (difficult or laboured respiration)
- Fall
- Sensory disturbance (sense disturbance)
- Upper respiratory tract infection
- Bowen's disease (early stage of skin cancer)
- Haemorrhage intracranial (bleeding within the skull)
- Peripheral swelling
- Rotator cuff repair
- Sleep disorder
male:
n/a
What are the common drug interactions of Myrbetriq and Activella, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Sensory disturbance (sense disturbance)
- Upper respiratory tract infection
- Dyspnoea (difficult or laboured respiration)
60+:
- Bowen's disease (early stage of skin cancer)
What are the existing conditions these people have? *
- Multiple Myeloma (cancer of the plasma cells): 5 people, 45.45%
- Sleep Disorder: 3 people, 27.27%
- Depression: 3 people, 27.27%
- Insomnia (sleeplessness): 3 people, 27.27%
- Urinary Incontinence (inability to control the flow of urine and involuntary urination): 2 people, 18.18%
- Cystitis Interstitial (unknown cause characterized by bladder pain): 2 people, 18.18%
- Dental Caries: 2 people, 18.18%
- Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 18.18%
- Fungal Infection: 2 people, 18.18%
- Itching: 2 people, 18.18%
* Approximation only. Some reports may have incomplete information.
Do you take Myrbetriq and Activella?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Myrbetriq and Activella:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Myrbetriq:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Activella:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Myrbetriq and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Activella and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on mirabegron and estradiol; norethindrone acetate (the active ingredients of Myrbetriq and Activella, respectively), and Myrbetriq and Activella (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Heparin Sodium cause Addison'S Disease? - 5 seconds ago
- Tongue Injury and drugs of ingredients of fluticasone propionate - 26 seconds ago
- Could Tamsulosin cause Full Blood Count Decreased? - 33 seconds ago
- Could Folvite cause Haematuria Aggravated? - 33 seconds ago
- Could Bidil cause Diarrhea Aggravated? - 36 seconds ago
- Itching and drugs of ingredients of metronidazole - 42 seconds ago
- Could Plaquenil cause Photosensitivity Reaction? - 43 seconds ago
- Alendronate Sodium vs. Premarin, side effect and effectiveness comparison - 44 seconds ago
- Polyarthritis and drugs of ingredients of mesalamine - 46 seconds ago
- Could Febuxostat cause Hypercholesterolaemia Aggravated? - 49 seconds ago